Download the Congress Abstract Book 2021
Congress will be broadcasted through the WHOVA platform. After completing your registration, you will receive a separate email invitation from Whova to register and get access to the congress platform.
You also can directly create an account on Whova, but you HAVE to create your account with the SAME email used to register at the Congress.
ALL BROADCASTED PRESENTATIONS AND LIVE PANEL DISCUSSIONS WILL BE MADE AVAILABLE TO REGISTERED ATTENDEES ON THE EVENING OF EACH DAY OF THE CONGRESS.
This program is subject to change without notice at any time. Times are in CET. All sessions will be followed by 30 minutes of a live panel discussion.
WEDNESDAY, JANUARY 13th
Session A, 9 to 12 (break 10:30 to 11), « Presentation of the Galaxy Guide & Hands-on »
LUNCH BREAK 12 to 13
Opening Session 13 to 15
Welcome messages
BREAK 15 to 15:30
Session B, 15:30 to 17, « Rare Diseases Foresight: Panel discussion (EU/America/Asia/AU) »
THURSDAY, JANUARY 14th
Session C, 10 to 12, « Diagnostic, WGS, artificial intelligence, new technologies » Chair: Jacqui Beckmann
Panel discussion: All speakers and patient representative (Virginie Bros-Facer – Eurordis and Maja Bartoszewicz Moritz)
LUNCH BREAK 12 to 13
Session D, 13 to 15, “Molecular etiology of RD, innovative clinical trials, precision medicine“ Chair: PJ Brooks
Panel discussion: All speakers and patient representative (Christian Rubio – Global Gene)
BREAK 15 to 15:30
Session E, 15:30 to 17, “Advanced therapies: gene editing, cell therapy” Chair: Joseph Scheeren
Panel discussion: All speakers and patient representative (Oxana Illiach – CORD)
FRIDAY, JANUARY 15th
Session F, 10 to 12, « Patients as drivers in drug development and clinical trials » Chairs: Durhane Wong-Rieger and Samantha Parker
Panel discussion: All speakers and patient representative (Sharon Terry – Genetic Alliance)
LUNCH BREAK 12 to 13
Session G, 13 to 15, « Access to diagnostic and drugs for all » Chair: William Gahl
Panel discussion: All speakers and patient representatives (Alba Ancochea-Diaz – ALIBER; Ramaiah Muthyala – I-ORD; Samuel Agyei Wiafe – Rare Diseases Ghana; Tanja Collin-Histed – International Gaucher Alliance; Eda Selebatso – BORDIS Botswana)
BREAK 15 to 15:30
Session H, 15:30 to 17, “Methodologies to assess the effect of diagnosis and therapies on RD patients“ Chair: David Pearce
Panel discussion: All speakers and patient representatives (Dimitrios Athanasiou – World Duchenne Organization; Vanessa Boulanger – NORD)
Program updated January 12, 2021